Biodexa Pharmaceticals Company Insiders
| BDRX Stock | 5.62 0.69 14.00% |
Biodexa Pharmaceticals employs about 21 people. The company is managed by 6 executives with a total tenure of roughly 49 years, averaging almost 8.0 years of service per executive, having 3.5 employees per reported executive. Break down of Biodexa Pharmaceticals' management performance can provide insight into the company performance.
Biodexa |
Biodexa Pharmaceticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3752) % which means that it has lost $0.3752 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9723) %, meaning that it created substantial loss on money invested by shareholders. Biodexa Pharmaceticals' management efficiency ratios could be used to measure how well Biodexa Pharmaceticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.98 in 2024. Return On Capital Employed is likely to rise to -1.53 in 2024. At this time, Biodexa Pharmaceticals' Total Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 3.2 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 3.3 M in 2024.Common Stock Shares Outstanding is likely to rise to about 33.2 K in 2024, whereas Net Loss is likely to drop (6.6 M) in 2024.
Biodexa Pharmaceticals Workforce Comparison
Biodexa Pharmaceticals is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 40,558. Biodexa Pharmaceticals adds roughly 21.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Biodexa Pharmaceticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biodexa Pharmaceticals Price Series Summation is a cross summation of Biodexa Pharmaceticals price series and its benchmark/peer.
Biodexa Pharmaceticals Notable Stakeholders
A Biodexa Pharmaceticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biodexa Pharmaceticals often face trade-offs trying to please all of them. Biodexa Pharmaceticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biodexa Pharmaceticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephen Stamp | CFO, CEO | Profile | |
| Nicola Tuckwell | VP Operations | Profile | |
| Dmitry MD | Chief Officer | Profile | |
| Daniel MBA | Vice Technology | Profile | |
| Fiona Sharp | Group Controller | Profile | |
| Steve Ellul | Chief Officer | Profile |
About Biodexa Pharmaceticals Management Performance
The success or failure of an entity such as Biodexa Pharmaceticals often depends on how effective the management is. Biodexa Pharmaceticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biodexa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biodexa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.93) | (0.98) | |
| Return On Capital Employed | (1.61) | (1.53) | |
| Return On Assets | (0.67) | (0.71) | |
| Return On Equity | (1.51) | (1.59) |
Please note, the imprecision that can be found in Biodexa Pharmaceticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biodexa Pharmaceticals. Check Biodexa Pharmaceticals' Beneish M Score to see the likelihood of Biodexa Pharmaceticals' management manipulating its earnings.
Biodexa Pharmaceticals Workforce Analysis
Traditionally, organizations such as Biodexa Pharmaceticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biodexa Pharmaceticals within its industry.Biodexa Pharmaceticals Manpower Efficiency
Return on Biodexa Pharmaceticals Manpower
| Revenue Per Employee | 18.1K | |
| Revenue Per Executive | 63.5K | |
| Net Loss Per Employee | 337.1K | |
| Net Loss Per Executive | 1.2M | |
| Working Capital Per Employee | 69.6K | |
| Working Capital Per Executive | 243.5K |
Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.